Cancer research is undergoing constant change, driven by innovative approaches in immunotherapy and precision diagnostics. Modern research approaches aim to understand the mechanisms underlying the development of resistance – for example, through tumour-associated inflammatory processes – and to open up new therapeutic windows. At the same time, technological breakthroughs in infrared diagnostics are enabling ever more precise early detection and monitoring of cancer. The aim of this translational research is to translate scientific findings directly into sustainable improvements in diagnosis, treatment and prevention.
Since its foundation in 1975, the Wilhelm Sander Foundation has supported excellent medical research and, during this time, has awarded over 350 million euros to around 2,500 projects. A particular focus is on collaboration with Ludwig Maximilian University of Munich (LMU) and LMU Medical Centre, where numerous high-calibre research projects are continuously funded.
To mark our 50th anniversary, we are delighted to be organising a scientific symposium in collaboration with the LMU Faculty of Medicine. As part of this event, leading experts will present current projects in the fields of T-cell therapy, thromboinflammation and innovative broadband infrared diagnostics. The symposium offers an opportunity to reflect on the achievements of our long-standing funding work and to further deepen the intensive exchange of ideas between research and clinical practice in Munich.